Some studies indicate that TP53BP1 variants may have protective effects on squamous cell carcinoma of the head and neck (SCCHN) risk but such effects were confined to TP53 Arg72Pro variant allele/haplotype carriers [5], [8]. Here, TP53BP1 is linked to head and neck squamous cell carcinoma.